Compare HOFT & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOFT | CLNN |
|---|---|---|
| Founded | 1924 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.9M | 120.6M |
| IPO Year | 1999 | N/A |
| Metric | HOFT | CLNN |
|---|---|---|
| Price | $13.05 | $5.32 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | 32.2K | ★ 110.3K |
| Earning Date | 12-11-2025 | 11-13-2025 |
| Dividend Yield | ★ 3.58% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $375,494,000.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.25 | $82.05 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.82 | N/A |
| 52 Week Low | $7.34 | $2.28 |
| 52 Week High | $13.85 | $13.50 |
| Indicator | HOFT | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 67.32 | 41.56 |
| Support Level | $10.94 | $4.68 |
| Resistance Level | $13.47 | $5.40 |
| Average True Range (ATR) | 0.56 | 0.58 |
| MACD | 0.12 | 0.02 |
| Stochastic Oscillator | 74.36 | 37.61 |
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.